This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Corrigendum to "A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells" [Bioorg. Med. Chem. 65 (2022) 116761]. (15th January 2023)
Record Type:
Journal Article
Title:
Corrigendum to "A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells" [Bioorg. Med. Chem. 65 (2022) 116761]. (15th January 2023)
Main Title:
Corrigendum to "A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells" [Bioorg. Med. Chem. 65 (2022) 116761]